EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 2.075
March 31, 2026 -0.1541
December 31, 2025 -0.3943
September 30, 2025 1.192
June 30, 2025 0.9601
March 31, 2025 1.029
December 31, 2024 0.8319
September 30, 2024 -2.886
June 30, 2024 -3.119
March 31, 2024 -3.494
December 31, 2023 -3.552
September 30, 2023 -1.682
June 30, 2023 -1.565
March 31, 2023 -1.509
December 31, 2022 -1.437
September 30, 2022 -1.400
June 30, 2022 -1.310
March 31, 2022 -0.9389
December 31, 2021 -0.5817
September 30, 2021 -0.3474
June 30, 2021 -0.1791
March 31, 2021 -0.2889
December 31, 2020 -0.4115
September 30, 2020 -0.4527
June 30, 2020 -0.438
Date Value
March 31, 2020 -0.4775
December 31, 2019 -0.5225
September 30, 2019 -0.5036
June 30, 2019 -0.9983
March 31, 2019 -1.212
December 31, 2018 -1.331
September 30, 2018 -2.368
June 30, 2018 -2.46
March 31, 2018 -2.25
December 31, 2017 -2.21
September 30, 2017 -1.81
June 30, 2017 -1.44
March 31, 2017 -2.02
December 31, 2016 -2.57
September 30, 2016 -2.24
June 30, 2016 -2.27
March 31, 2016 -1.77
December 31, 2015 -1.15
September 30, 2015 -0.7504
June 30, 2015 -0.3404
March 31, 2015 0.0029
December 31, 2014 0.0829
September 30, 2014 -0.0325
June 30, 2014 -0.3425
March 31, 2014 -0.4158

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Natera, Inc. -1.368
Caris Life Sciences, Inc. 0.3723
Myriad Genetics, Inc. -1.199
BioRestorative Therapies, Inc. -22.40
Exagen, Inc. -0.8057